Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model

Published:1998-05-06 Issue:1 Volume:42 Page:77-83
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Guchelaar Henk-Jan,Vermes Istvan,Koopmans Richard P.,Reutelingsperger Chris P. M.,Haanen Clemens

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800050788.pdf

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of anticancer effect of micelle-encapsulated doxorubicin using gamma-distributed delay model;Journal of Drug Delivery Science and Technology;2024-01

2. Influence of the treatment with the antineoplastic agents 5-fluorouracil and cisplatin on the severity of experimental periodontitis in rats;Supportive Care in Cancer;2021-10-11

3. Reduction in the Number of Varicella-Zoster Virus-Specific T-Cells in Immunocompromised Children with Varicella;The Tohoku Journal of Experimental Medicine;2020

4. Comparison of transport of chemotherapeutic drugs in voxelized heterogeneous model of human brain tumor;Microvascular Research;2019-07

5. The influence of Cisplatin‐based chemotherapy on the osseointegration of dental implants: An in vivo mechanical and histometrical study;Clinical Oral Implants Research;2019-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP